选择语言/Select Language

Company -> Our History

Since 1990´s, Professors and our core technology team from Tsinghua University have developed the new Transient Elastography (TE) technologies and studied the application of TE technologies to in-vitro non-invasive diagnosis of liver fibrosis.
 
In 2010, HISKY MEDICAL established and named Jiangsu Leading Enterprise Established by High-level Overseas Talents and Wuxi 530-program Enterprise and moved into Taihu International Science& Technology Park, National Hi-tech Development Zone.
 
In 2010, HISKY MEDICAL developed the image-guided non-invasive liver fibrosis detection system FibroTouch. The system has been tested by Center for Medical Device Evaluation, SFDA and passed clinical trial in several famous hospitals in China.
 
In 2011, FibroTouch obtained its Medical Device Registration Certificate (SFDA certificate) issued by State FDA.


In 2014, ISO 13485 certified by TUV and received first CE Mark clearance.
  
In 2017, 1000 units of FibroTouch installed in China and international markets.
 
In 2018, FibroTouch approved by the US FDA.